Company Profile
IGC Pharma, Inc. Stock Price, News & Analysis
- Ticker:
- IGC
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.25 USD (-0.83%)
Close
Last updated: August 6, 2026
29M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, IGC closed down 0.83% at $0.2499. No new same-company headline was identified in the current news window.
Company overview
Business overview
IGC Pharma is a biopharmaceutical company exploring cannabinoid-based and other therapeutic programs, including neuropsychiatric and metabolic concepts. Its identity has been tied to a broad but still early-stage development story.
Geographic Base and Sector Classification
IGC Pharma is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotech with a neuropsychiatry and cannabinoid angle.
Business Model Characteristics
The company depends on early development work, regulatory pathfinding, and capital efficiency. Investors typically watch program updates, preclinical or early clinical signals, and whether the company can sharpen its focus.
Position Within the Biotechnology Landscape
IGC occupies a speculative small-cap biotechnology niche. It is more of an early-stage concept story than a mature clinical platform.
Future catalysts
IGC Pharma’s catalysts are its cannabis-derived and neuro-related programs, plus any operating update that clarifies commercial progress. The market will care about whether the company can turn the platform into a real business.
Recent news
- 01
IGC Announces Rebranding, Changes Name to IGC Pharma, Inc.
Source: IGC Pharma, Inc.
- 02
IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022
Source: IGC Pharma, Inc.
- 03
IGC to be Featured in Feb. 10 Radius Research Investor Webinar
Source: IGC Pharma, Inc.
- 04
IGC Receives No Objection Letter from Health Canada
Source: IGC Pharma, Inc.
- 05
IGC Announces Updated Life Sciences Presentation
Source: IGC Pharma, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of IGC Pharma, Inc. (IGC)?
IGC Pharma, Inc. (IGC) most recently closed at 0.25 USD, a -0.83% move versus the previous session.
What is the market cap of IGC Pharma, Inc. (IGC)?
IGC Pharma, Inc. currently has a market capitalization of 29M USD on BioPharmSignal.
What does IGC Pharma, Inc. do?
IGC Pharma is a biopharmaceutical company exploring cannabinoid-based and other therapeutic programs, including neuropsychiatric and metabolic concepts. Its identity has been tied to a broad but still early-stage development story.
On which exchange is IGC stock listed?
IGC Pharma, Inc. (IGC) is associated with NYSE, United States, Biopharma.
What is Pharma?
IGC Pharma’s catalysts are its cannabis-derived and neuro-related programs, plus any operating update that clarifies commercial progress.
Which conditions is IGC Pharma, Inc. targeting with Pharma?
IGC Pharma, Inc. is associated with metabolic disease based on its company overview and current catalyst commentary.
How does IGC Pharma, Inc. describe recent progress with Pharma?
IGC Pharma’s catalysts are its cannabis-derived and neuro-related programs, plus any operating update that clarifies commercial progress.
What future catalysts are investors watching for IGC Pharma, Inc.?
IGC Pharma’s catalysts are its cannabis-derived and neuro-related programs, plus any operating update that clarifies commercial progress. The market will care about whether the company can turn the platform into a real business.